Figure 1 (Sodium 01)
Sodium Chloride Injection, Solution
Product Images NDC 0409-7101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 0409-7101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Sodium 02)
Figure 3 (Sodium 03)
Figure 4 (Sodium 04)
Figure 5 (Sodium 05)
Figure 6 (Sodium 06)
Figure 7 (Sodium 07)
Hospira Logo (Sodium 08)
Principal Display Panel (50 mL Bag Label)
This is a description indicating instructions to pull inner plug/stopper and mix the drug before use. It refers to an Add-Vantage™ unit containing 0.9% S0DIUM CHLORIDE for intravenous use. The container is a single-dose non-pyrogenic and sterile container that should only be used as directed for hospital dosage. The text also includes the drug's composition per 100mL and pH level. The drug is distributed by HOSPIRA, INC.*
Principal Display Panel (100 mL Bag Label)
This is a sterile and non-pyrogenic 100mL container of 0.9% sodium chloride solution that is meant for intravenous use only. It contains 500mg of sodium chloride and its pH is 5.6. Its usual dosage and other relevant information can be found in the package insert. Before use, the drug should be mixed by pulling the inner plug/stopper. The container should not be used if it is damaged or is not clear. The LOT number and expiration date can be found in the target area.*
Principal Display Panel (50 ML AND 100 ML BAG OVERWRAP LABEL – NDC 0409-7101)
This text provides instructions for the use of Five/ADD-Vantage™ Units within the ADD-Vantage™ system components with a recommended temperature of 20 to 25°C (68 to 77°F). The overwrap provides a moisture barrier, and the units should be used within 30 days of opening the overwrap. The sterility of the unit may be compromised if minute leaks are found after removing the overwrap, in which case it should be discarded. The product is distributed by Hospira, Inc., in Lake Forest, IL, and is for prescription use only.*
Principal Display Panel (250 mL Bag Label)
RO0-Varfage™ Unie WOC 0409-7101-02 is a 0.9% sodium chloride injection marked in a single-dose container for intravenous use. The solution contains sodium chloride, electrolytes (Sodium and Chloride), and has pH 5.6. It is sterile and nonpyrogenic but must be used only with ADD-Vantage™ System Components. The usual dosage is available in the insert, and the solution must not be used in series connections. The product is distributed by Hospira, Inc., and must be used only by prescription. Contains DEHP 1447 6601.*
Principal Display Panel (250 mL Bag Overwrap Label)
This is a description for One/ADD-Vantage™ Unit, which is a system component used with ADD-Vantage™. The overwrap acts as a moisture barrier and it needs to be opened by peeling at a corner. The unit should be used within 30 days of opening the overwrap and before the expiration date printed on it. The unit must be stored at a temperature between 20 to 25°C (68 to 77°F) and protected from freezing. After removing the overwrap, one must check for minute leaks by squeezing the container firmly. If any leaks are found, the unit needs to be discarded as its sterility may be impaired. The description includes a reference number (Rx only 14475901) but no other information on what the product is for or how it is used.*
Principal Display Panel (50 mL Bag Label)
This product is a sodium chloride injection used for intravenous therapy. The container has to be mixed before use and the plug/stopper should be removed. The product has a 0.45% sodium chloride concentration, and each 100 mL contains 450 mg of electrolytes. The pH is 5.6, and it is for use only with ADD-Vantage™ system components. The product is non-pyrogenic and sterile, and for intravenous use only. The package insert outlines the usual dosage, and the container should only be used if the solution is clear and the container is undamaged. The product should not be used in series connections. The container contains DEHP, and it is manufactured by Hospira, Inc. in the USA.*
Principal Display Panel (50 mL Bag Overwrap Label)
This is a set of Five/ADD-Vantage™ units that are meant to be used with ADD-Vantage™ system components. The packaging is a moisture barrier, and the units should be used within 30 days of opening the overwrap. They should be checked for leaks before use and discarded if any are found. The units must be stored at a temperature between 20 to 25°C (68 to 77°F). The product is distributed by Hospira, Inc. in Lake Forest, IL, and is for prescription use only.*
Principal Display Panel (250 mL Bag Label)
This text is a description of a medication for intravenous use. It is a 0.45% sodium chloride injection, with each 100 mL containing 430 mg of sodium chloride and electrolytes. It should be mixed before use and can only be used with the ADD-Vantage™ 1 ()() system components. It is a sterile, non-pyrogenic single-dose container that should not be used in series connections. The usual dosage instructions can be found in the insert. The manufacturer is Hospira, Inc. located in Lake Forest, Illinois.*
Principal Display Panel (250 mL Bag Overwrap Label)
This is a description for the One/ADD-Vantage™ Unit that should be opened at the corner. This unit should only be used with ADD-Vantage™ system components. It has an overwrap that acts as a moisture barrier and it should be used within 30 days of opening. The unit should be stored between 20 to 25°C (68 to 77°F), and should be protected from freezing. After removing the overwrap, the user should check for minute leaks by squeezing the container firmly. If leaks are found, the unit should be discarded as sterility may be impaired. The information on the unit indicates that it is only for hospital use and is distributed by Hospira, Inc. in Lake Forest, IL.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
